Clinical studies recruiting near Sheffield

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Phase 3 · Weston Park Hospital · Eli Lilly and Company · NCT07218380 Symptoms and Functions in Patients With COPD and Chronic Bronchitis Switching From CIG to THS
NA · Panthera Biopartners · Philip Morris Products S.A. · NCT07108166 Remote Ischaemic Conditioning for Post-surgical Complications in Hip Fracture (RIC-FRACTURE)
NA · Sheffield Teaching Hospitals NHS Foundation Trust · Sheffield Teaching Hospitals NHS Foundation Trust · NCT07178041 A Trial of "APL-9796'' in Adults With Pulmonary Hypertension
Phase 2 · Sheffield Teaching Hospitals · Apollo Therapeutics Ltd · NCT06846554 Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease
Phase 2/Phase 3 · Local Institution - 0230 · Bristol-Myers Squibb · NCT07106762 Evaluating the Effects of Tasimelteon vs. Placebo in Treating Pediatric Insomnia
Phase 3 · Vanda Investigational Site · Vanda Pharmaceuticals · NCT06953869 Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
Phase N/A · Galderma Investigational Site 6389 · Galderma R&D · NCT06988605 This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in
Phase 3 · Weston Park Hospital · Pfizer · NCT06758401 Methods of T Cell Depletion Trial (MoTD)
Phase 2 · Royal Hallamshire Hospital · University of Birmingham · NCT04888741 A Study Evaluating the Effects of Filgotinib in Children and Teenagers With Ulcerative Colitis
Phase 3 · Sheffield Children's Hospital · Alfasigma S.p.A. · NCT06865417 A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
Phase 1 · Sheffield Teaching Hospitals NHS Foundation Trust · Pfizer · NCT07206225 Study to Assess Safety, Efficacy, and Cellular Kinetics of YTB323 in Generalized Myasthenia Gravis
Phase 1/Phase 2 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT06704269 Biomarkers of aHSCT
Phase N/A · Sheffield Teaching Hospitals NHS Foundation Trust · Sheffield Teaching Hospitals NHS Foundation Trust · NCT06195800 Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov
Phase 3 · Syed Research Consultants LLC · Amgen · NCT07037433 Open Label Trial Studying the Safety and Effectiveness of ILUVIEN® (190μg) in Children and Adolescents, Who Have Recurre
Phase 4 · Sheffield Teaching Hospitals NHS Foundation Trust and Sheffi · Alimera Sciences · NCT06539481 A Study of Rapcabtagene Autoleucel in Active, Refractory Systemic Lupus Erythematosus (SLE) or Lupus Nephritis (LN) Pati
Phase 2 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT06581198 Hemithyroidectomy or Total-Thyroidectomy in 'Low-risk' Thyroid Cancers
NA · Sheffield Teaching Hospitals · University College, London · NCT05604963 Understanding the Long-Term Management of Organic Acidemia Patients With CARBAGLU®: A Mixed Methods Approach
Phase N/A · Sheffield Children's Hospital NHS Foundation Trust · RECORDATI GROUP · NCT04176523 A Study of How the Medicine Called "Etrasimod" Works in Children With the Gut Disease Called Ulcerative Colitis
Phase 2 · Sheffield Children's Hospital · Pfizer · NCT07470879 Study on Optimal Temperature During Cardiopulmonary Bypass (THERMIC-4)
NA · Northern General Hospital, Sheffield Teaching Hospitals NHS · University of Leicester · NCT05996120 Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis
Phase 3 · Sheffield teaching hospital NHS foundation trust · Gilead Sciences · NCT06051617 PHOENIX DDR/Anti-PD-L1 Trial: A Pre-surgical Window of Opportunity and Post-surgical Adjuvant Biomarker Study of DNA Dam
Phase 2 · Weston Park Hospital · Institute of Cancer Research, United Kingdom · NCT03740893 A Phase 1/2, First-in-Human Study On ODM-212 In Subjects With Selected Advanced Solid Tumours
Phase 1/Phase 2 · Weston Park Hospital · Orion Corporation, Orion Pharma · NCT06725758 Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
Phase 3 · Panthera Biopartners - Sheffield · Eli Lilly and Company · NCT07353931 Closed Loop and Education for Hypoglycemia Awareness Restoration
NA · University of Sheffield · Milton S. Hershey Medical Center · NCT06325202 A Study to Evaluate ALN-5288 in Patients With Alzheimer's Disease
Phase 1 · Clinical Trial Site · Alnylam Pharmaceuticals · NCT07214727 Duroplasty for Injured Cervical Spinal Cord With Uncontrolled Swelling
NA · Sheffield Teaching Hospitals NHS Foundation Trust · St George's, University of London · NCT04936620 The Use of Advanced Imaging in HFpEF
Phase N/A · Sheffield Teaching Hospitals NHS Foundation Trust · Sheffield Teaching Hospitals NHS Foundation Trust · NCT06905405 A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy
Phase 3 · Northern General Hospital · Takeda · NCT06963827 A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer
Phase 3 · Sheffield Teaching Hospitals NHS Foundation Trust · Janssen Research & Development, LLC · NCT06319820

Look up another city

Look up another condition